HARVARD BIOSCIENCE INC Return Tang Equity
Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
- HARVARD BIOSCIENCE INC return tang equity for the quarter ending 2026-06-30 was 131.46%, a 92.35% decline year-over-year.
- HARVARD BIOSCIENCE INC return tang equity for the quarter ending 2026-03-31 was 162.58%, a 88.65% decline year-over-year.
- HARVARD BIOSCIENCE INC return tang equity for the quarter ending 2025-12-31 was 1747.30%, a 452.29% increase year-over-year.
- HARVARD BIOSCIENCE INC return tang equity for the quarter ending 2025-09-30 was 1487.98%, a 344.06% increase year-over-year.
- HARVARD BIOSCIENCE INC return tang equity for fiscal 2025 was 1747.30%, a 452.29% increase from fiscal 2024.
- HARVARD BIOSCIENCE INC return tang equity for fiscal 2024 was 316.37%, a change of 2213.60% from fiscal 2023.
- HARVARD BIOSCIENCE INC return tang equity for fiscal 2023 was -1897.22%, a 1062.97% decline from fiscal 2022.
- HARVARD BIOSCIENCE INC return tang equity for fiscal 2022 was 197.02%, a 881.67% increase from fiscal 2021.
- Available history
- 2009-12-31 to 2026-06-30
- Data captured
Historical Return Tang Equity
Annual Return Tang Equity
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |